TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05527561

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin dance: Rumba
Description: Latin dance is a kind of sports dance, which originated in Latin America, includes the rumba, samba, Cha Cha Cha, bullfighting dances and cowboy dances. The intensity of the training is increasing in the first 20 minutes, and the intensity is gradually decreasing in the next 5 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin dance: Rumba
Description: Latin dance is a kind of sports dance, which originated in Latin America, includes the rumba, samba, Cha Cha Cha, bullfighting dances and cowboy dances. The intensity of the training is increasing in the first 20 minutes, and the intensity is gradually decreasing in the next 5 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin dance: Cha Cha Cha
Description: Latin dance is a kind of sports dance, which originated in Latin America, includes the rumba, samba, Cha Cha Cha, bullfighting dances and cowboy dances. The intensity of the training is increasing in the first 20 minutes, and the intensity is gradually decreasing in the next 5 minutes.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Latin dance: Cha Cha Cha
Description: Latin dance is a kind of sports dance, which originated in Latin America, includes the rumba, samba, Cha Cha Cha, bullfighting dances and cowboy dances. The intensity of the training is increasing in the first 20 minutes, and the intensity is gradually decreasing in the next 5 minutes.
Study: NCT05357235

Intervention type: DRUG
Intervention: PEG-IFN
Description: PEG-IFN 180 or 135 micrograms, subcutaneously injected once a week, with a personalized treatment course of 24 weeks
Study: NCT02928094

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ad5FGF-4
Description: Ad5FGF-4 administered via intracoronary infusion using standard balloon catheter, and under conditions of transient ischemia.

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo buffer administered via intracoronary infusion using standard balloon catheter, without transient ischemia.
Study: NCT05418049

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Baclofen
Description: 30mg - Supplied as 10mg and 20mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Memantine
Description: two 10 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Roflumilast
Description: 250 mcg capsule

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo pill
Study: NCT06190314

Intervention type: DIAGNOSTIC_TEST
Intervention: Measure serum vitamin b12 levels
Description: Measure the vitamin b-12 levels in patients that are admitted for stroke of any kind

Intervention type: DIAGNOSTIC_TEST
Intervention: Measure serum vitamin b12 levels
Description: Measure the vitamin b-12 levels in patients that are admitted for stroke of any kind
Study: NCT05791591

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NUV001 - IR
Description: Daily supplementation with 1000 mg of NUV001 (in two administration orally) immediate release gel capsule formulation for 90 days in total

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: NUV001 - GR
Description: Daily supplementation with 1000 mg of NUV001 (in two administration orally) gastro resistant gel capsule formulation for 90 days in total

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo containing starch Powder (1000 mg, daily in two administration orally for 90 days)
Study: NCT04940923

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: T2 weighted and DTI MRI images of brachial plexus and wrist. Quantitative sensory tests include warm and cold detection and pain thresholds, paradoxical heat sensation, mechanical detection thresholds, mechanical pain sensation and thresholds, wind up ratios, vibration thresholds and pressure pain thresholds.~Clinical tests include standard neurological tests and test for heightened nerve mechanosensitivity.~Blood serum to analyse inflammatory proteins. Questionnaires include neck disability index, painDETECT, PTSD8, pain catastrophising scale, eq-5D-5L, DASS 42 and global perceived recovery

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI
Description: T2 weighted and DTI MRI images of brachial plexus and wrist. Quantitative sensory tests include warm and cold detection and pain thresholds, paradoxical heat sensation, mechanical detection thresholds, mechanical pain sensation and thresholds, wind up ratios, vibration thresholds and pressure pain thresholds.~Clinical tests include standard neurological tests and test for heightened nerve mechanosensitivity.~Blood serum to analyse inflammatory proteins. Questionnaires include neck disability index, painDETECT, PTSD8, pain catastrophising scale, eq-5D-5L, DASS 42 and global perceived recovery
Study: NCT06488118

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R848
Description: Inhaled R848 dose ranging from 0.1 to 100 μg/mL

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R848
Description: Inhaled R848 dose ranging from 0.1 to 100 μg/mL

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R848
Description: Inhaled R848 dose ranging from 0.1 to 100 μg/mL

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R848
Description: Inhaled R848 dose ranging from 0.1 to 100 μg/mL

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R848
Description: Inhaled R848 dose ranging from 0.1 to 100 μg/mL

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Inhaled Saline control

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline
Description: Inhaled Saline control
Study: NCT06022770

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nutritional counseling，Enteral Nutrition
Description: patients with esophageal cancer and gastric cancer undergoing chemotherapy were selected as the study objects for nutritional risk screening, malnutrition assessment and quality of life assessment. Randomly enter the nutrition consultation group (NC) and nutrition support treatment group (NST)
Study: NCT06040619

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Therapy Together
Description: 8-week caregiver-led pediatric constraint-induced movement therapy program

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Usual Care
Description: 8 weeks of usual care received in an early intervention therapy program
Study: NCT06127212

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg film-coated tablet
Description: One tablet of the test drug was given orally (swallowed with 240 mL of 20% glucose solution in water), after an overnight fast.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia
Description: One tablet of the reference drug was given orally (swallowed with 240 mL of 20% glucose solution in water), after an overnight fast.
Study: NCT03423355

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dapagliflozin (Forxiga®)
Description: 10mg p.o. daily

Intervention type: DRUG
Group type: OTHER
Intervention: Hydrochlorothiazide 25 mg
Description: 25mg p.o. daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo matching Dapagliflozin
Description: Placebo matching Dapagliflozin p.o. daily
Study: NCT06119581

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY3537982
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin
Description: Administered IV.
Study: NCT05752864

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: spine manual therapy
Description: The manual treatment method applied to the sacroiliac joint used high-velocity, low amplitude (HVLA).

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Superficial heat therapy
Description: In the physical therapy used in this study, it was applied for 20 minutes using conventionally used superficial heat therapy.
Study: NCT04942639

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JOE
Description: Audiovisual support by the robot when taking maintenance treatments at home.
Study: NCT06488950

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GC203 TIL(gene-edited TIL) or autologous TILs
Description: the candidates will be assigned to GC203 TIL(gene-edited TIL) group or autologous TILs group according the volume of TIL sample

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GC203 TIL(gene-edited TIL) or autologous TILs
Description: the candidates will be assigned to GC203 TIL(gene-edited TIL) group or autologous TILs group according the volume of TIL sample
Study: NCT05621863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.
Study: NCT06103058

Intervention type: OTHER
Intervention: Cross sectional
Description: Cross sectional
Study: NCT06271980

Intervention type: OTHER
Intervention: ENCORE
Description: A panel of microRNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.
Study: NCT05621863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 1
Description: A meal challenge will be provided that contains 1 serving of peaches and 2 servings of strawberries as a smoothie and 2 servings of tomatoes and 1 serving of carrot as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.
Study: NCT04882163

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220
Study: NCT05621863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.
Study: NCT04882163

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CC-220
Description: CC-220

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin
Description: Polatuzumab vedotin
Study: NCT05621863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.
Study: NCT06271980

Intervention type: OTHER
Intervention: ENCORE
Description: A panel of microRNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.

Intervention type: OTHER
Intervention: ENCORE
Description: A panel of microRNA, whose expression level is tested in macro-dissected formalin-fixed and paraffin-embedded (FFPE) samples derived from the primary tumor.
Study: NCT05621863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 2
Description: A meal challenge will be provided that contains 1 serving of banana and 2 servings of peaches as a smoothie and 1 serving of tomatoes and 2 servings of green beans as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.
Study: NCT05621863

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 1 Meal Challenge 3
Description: A meal challenge will be provided that contains 2 serving of bananas and 1 serving of strawberries as a smoothie and 1 serving of green beans and 2 servings of carrots as a vegetable dish.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 2 Typical American Diet
Description: The diet will provide sufficient calories for weight maintenance and will contain refined grains and low amounts of fruits and vegetables, representative of the typical American diet. No bananas, strawberries, peaches, green beans, carrots, or tomatoes will be provided.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 2 Typical American Diet Plus Test Foods
Description: This diet will provide sufficient calories for weight maintenance and will contain refined grains and low amounts of fruits and vegetables, representative of the typical American diet. Bananas, strawberries, peaches, green beans, carrots, and tomatoes will be provided in amounts less than or equal to 1 serving per day each.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aim 2 Dietary Guidelines for Americans Diet Plus Test Foods
Description: This diet will provide sufficient calories for weight maintenance and will contain whole grains and high amounts of fruits and vegetables, representative of the Dietary Guidelines for Americans. Bananas, strawberries, peaches, green beans, carrots, and tomatoes will be provided in amounts greater than or equal to 1 serving per day each.
Study: NCT06119581

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered IV.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Administered IV.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Pemetrexed
Description: Administered IV.
Study: NCT04882163

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Polatuzumab vedotin
Description: Polatuzumab vedotin

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab
Study: NCT06119581

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pemetrexed
Description: Administered IV.
Study: NCT05457257

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: olaparib
Description: 300 mg (2x 150 mg tablets) twice daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: enzalutamide
Description: 160 mg (4 x 40 mg capsules) once daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: abiraterone acetate
Description: 1,000 mg (4 x 250 mg tablets) once daily

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Prednisone
Description: 5mg(5mg x 1 tablet) twice daily
Study: NCT05183204

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paxalisib
Description: Patients will receive paxalisib starting at a dose of 45 mg/day. If well tolerated after 28 days, the dose of paxalisib will be increased to 60 mg/day.
Study: NCT04739436

Intervention type: DEVICE
Group type: OTHER
Intervention: Hearing amplification
Description: Bilateral vs. unilateral hearing aids for hearing loss
Study: NCT05183204

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paxalisib
Description: Patients will receive paxalisib starting at a dose of 45 mg/day. If well tolerated after 28 days, the dose of paxalisib will be increased to 60 mg/day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Patients will receive metformin on Cycle 1, Day 1 at a starting dose of 850 mg QD, and if tolerated, will be increased to 850 mg BID on Cycle 2, Day 1 (1700 mg/day). If that dose is tolerated, metformin will be increased to 850 mg TID (2550 mg/day) beginning on Cycle 3, Day 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Patients will receive metformin on Cycle 1, Day 1 at a starting dose of 850 mg QD, and if tolerated, will be increased to 850 mg BID on Cycle 2, Day 1 (1700 mg/day). If that dose is tolerated, metformin will be increased to 850 mg TID (2550 mg/day) beginning on Cycle 3, Day 1.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: The ketogenic diet is high-fat, low carbohydrate diet. Ketogenic diet will be maintained on a continuous basis starting on Cycle 1, Day 1 and continuing throughout the trial.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ketogenic Diet
Description: The ketogenic diet is high-fat, low carbohydrate diet. Ketogenic diet will be maintained on a continuous basis starting on Cycle 1, Day 1 and continuing throughout the trial.
Study: NCT05286801

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT and/or PET-CT

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT and/or PET-CT

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fludeoxyglucose F-18
Description: Given FDG

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fludeoxyglucose F-18
Description: Given FDG

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET-CT and/or FDG-PET

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET-CT and/or FDG-PET
Study: NCT04882163

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab
Study: NCT04739436

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hearing amplification
Description: Bilateral vs. unilateral hearing aids for hearing loss